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ABSTRACT 
Background:. Difficulties in meeting demand of blood transfusion by government hospitals have dictated the 
need for patronizing laboratories by both government and private hospitals.Objective: The study was undertaken 
to ascertain the prevalence HBsAg and hepatitis C Virus of blood donors in private laboratories in Lagos 
Nigeria.Result: A total of 315 participants were used for this work 298 were male (94.6%) Seventeen (17) 
5.4%were females.  4.8% tested positive for HBsAg. Male constitute 80% prevalence of the positive group. 
Analysis of gender related prevalence of HBsAg showed that prevalence was higher in females (17.3%) than 
males (4%).prevalence of 1.5%.was Hepatitis C (HVC Ab).positive participants are in the age range of 21-
30.Conclusion:  The result revealed a decline in prevalence of viral hepatitis among voluntary blood donors in 
Lagos Nigeria. 
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1.0 INTRODUCTION 
 Hepatitis is medical condition defined by the inflammation of liver.  It is characterized by the presence of 
inflammatory cells in the tissues of the organs. (Gimson A. E 1996). It may occur with limited or no symptoms. 
It leads to jaundice, anorexia and malaise. Hepatitis is cause by virus, toxins from alcohol, medications, 
industrial organic solvents, plants, and auto immune disease. There five main types of hepatitis that are caused 
by the virus A, B, C, D, and E. Hepatitis A&E are caused by eating infected food or water i.e. viral  infected  
foods or water,  anal-oral contact during sex. Nearly everyone who develops HAV makes a full recovery. It does 
not lead to chronic disease. Hepatitis B it is caused by HBV and is spread by contact with infected blood, semen, 
and other body fluids. It is contacted through unprotected sexual intercourse, infected sharps and syringes, breast 
milk and bite by infected person A survey conducted in Lagos and Bauchi showed a prevalence rate of Hbs Ag 
13.3% (Mahoney and Kame 1999). A prevalence of 8.3% was reported in Kaduna (Ibrahim 2005). A study of 
prevalence of hepatitis C virus among blood donors in Lagos in 2006 revealed a prevalence of 8.4% (Ayoola et 
al 2006). A prevalence of 14.3% was obtained for hepatitis B among HIV infected blood donors in Jos. (unike C. 
J. 2005). While a prevalence of 13.4% was obtained in apparently healthy blood donors in Lagos (Abdusalami 
1986).  . Hepatitis C ,is a Member of flavivirus have been discovered to play a primary role in post transfusion 
hepatitis, proclivity to establish long standing persistent infections, association with chronic cirrhosis and 
hepatocellular carcinoma. (Stanley and Edwin, 1995; Coursaget et al., 1990) it is spread through direct contact 
with blood of infected person, via blood and blood product, parenterally, from mother to child and by sexual 
contact (Alfredo et al., 1990). ). Hepatitis C infects About 2 billion people worldwide including 400million 
chronically infected cases (schemers GB. 2009).  It is hyperepidemic in sub sub-Sahara Africa and Asia. There 
are estimated 170 million Hcv carriers’ worldwide. (Lancet infects. Dis. 2002). 
 
The endemicity in the developing parts of the world is high with majority of people being seropositive.  Most 
people get infected at birth or in early childhood. In Nigeria, the prevalence rate of HCV varies between 5.8-
12.3% (Halim and Ajayi2000; Bojuwoye, 1997; Aliyu, 1996).. Hepatitis B and C pose a major public health 
problem worldwide. This is worsening in developing countries by poor economic status where patients are made 
to afford the costly therapy. (Waheed .u.2009 
 
Everywhere in the world, transfusion of human blood is an essential therapeutic procedure because it has no 
genuine substitution. The field of transfusion medicine has encountered a huge problem in providing safe blood 
and blood products; therefore there is a need to improve testing for transfusion transmissible diseases and the 
selection of blood donors because   blood transfusion can result in transmission of infectious diseases.   
Transmission of hepatitis via blood and blood products has made provision of safe blood difficult (olokoba A.B 
2003). Therefore screening of transfused blood is absolute necessity. 
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Donor blood safety gained serious importance since the documentation of blood born viral infection in donor 
blood; Blood safety is considered in biological and immunological aspects, improvement in the provision of safe 
blood in sub-Saharan Africa has been a major concern for various health authorities. However blood should be 
transfused when it becomes absolute necessity.  
 
The aim of this work is to find out the prevalence of hepatitis B and C among voluntary donors in private 
laboratories in Lagos.  
 
2.0 MATERIALS AND METHOD:- 
A total of three hundred and sixty eight voluntary donors between the ages of 21-68 from voluntary and 
commercial donors in private laboratories in Lagos were Screened for anti HCV and HBsAg from February to 
November 2011 .5ml of blood samples were collected and centrifuged at 3000 rpm for 10mins the plasma was 
screened for HBsAg using enzyme immunoassay technique. Hepatitis C was screened by ELISA techniques for 
the determination of anti- Hepatitis C V Ab. 
 
3.0    RESULTS AND DISCUSSION: -  
A total of 315 donors were used for this work. 298 males (94.6%) Seventeen (17) 5.4%were females. Donors 
used were in the age (20-70) years. The average age of donors used was thirty (30.2±3.0). majority of the donors 
were in the  age 21-30 this is in agreement with work done by olokooba et.al (2009) among voluntary donors in 
yola north eastern Nigeria, where they discovered an age range of 18-61and a mean of 31.3 years and modal 
range of 20-29 years. 
 
 it also showed similarity with the work of  Khan et al (2002) who found that their blood donors were in the age 
range of 18 to 60 years. It is also similar to the findings of Muktar et al (2005) in Zaria, Northwestern, Nigeria in 
which their donors had a mean age of 33 years even though their age ranged from19 to 42 years. However the 
donors in Jos, North-central, Nigeria were in the age range 21 to 50 years according to Egah et al (2004).  
 
Most of the donors in this work are male this is similar to work of olokoba earlier cited where 96.%of donors 
were male and equally close  to the 95% in the study of Egah et al (2004). Muktar et al (2005) found that 98% of 
their donors were males while Nwokediuko et al (2007) in their study in Enugu, South-eastern, Nigeria found 
that 91.8% of their donors were males and Ayolabi C.I (|2009) recorded 97% among donors in Lagos. However 
all the donors were males in the study of Elfaki et al (2008) among the Sudanese.  
 
 Fifteen donors 15 (4.8%) tested positive for HBsAg.  
This is lower than prevalence of 14.6% recorded in jos (uneke 2005) but higher than2.4% (olokooba 2009)  
higher than the 1.1% found by Ejele et al (2005) in the Niger Delta region of Nigeria. It is also higher than the 
1.2% found by Kagu et al (2005) in North-eastern, Nigeria. It is higher than 2.2% found by Bhatti el al (2007) in 
Pakistani donors.  higher  than 4.0% in the work of Abdalla et al (2005) in Kenyan donors; the 8.3% in the work 
of Muktar et al (2005); and the 8.8% found by Matee el al (1999) in Tanzanian donors. 
 
Furthermore, the HBV infection rate of 2.4% is lower than 14.6% recorded in jos in 2006(uneke 2005) lower 
than  10.0% found by Elfaki et al (2008) in Sudanese blood donors; the 10.6% in the work of Esumeh et al 
(2003) in South-south, Nigeria; and the 13.2% found by Fasola et al (2009) in Ibadan, South-western, Nigeria. 
Analysis of sex-related prevalence of HbsAg showed that more males were infected than the females Twelve 
(12) 4.0% male and three (3) females 17.3%,. This support previous work findings that multiple sexual 
partnerships and promiscuity are habits occurring with higher frequency among males than females in Nigeria   
(UNSN 2001). 
 
 This may explain the higher incidence of HBsAg among the male population. The positive donors were in age 
ranges 21-30(7) and 31-40(8) the highest positive prevalence of 7.1% was recorded in age group 31 -40 this 
agrees with the work of oyelabi (2006) and uneke (2005). This could be associated with sexual activity and 
intravenous drug use reported to be highest among Nigerians in their third decade of life (UNSN 2001).  
 
The prevalence was higher in females (17.3%) than males (4%). This could be as a result of the sample size and 
the facts that women hardly donate blood in private laboratories. The other age group recorded 0%.   
 
Prevalence among the positive group male constitutes 80% of the positive group. From our study two (2) 
participants tested positive to hepatitis C giving a prevalence of 1.5%.this agrees with the 1.5% found by Matee 
et al (1999) among blood donors in Tanzania.  
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) 




The HCV infection rate in this study is however lower than 8.3% recorded among voluntary donors in Lagos 
Island, Nigeria, between January to November2004 (Ayolabi et.al.2006).the 3.0% found by Ezeani et al (2006) 
in Southeastern, Nigeria; and the 3.7% found byNwokediukoet.al (2007).Furthermore, the HCV infection rate of 
1.5% is lower than the2.4% recorded in Yola (olokoba et.al) 3.9% found by Esumeh et al (2003), the 4.2% in the 
work of Bhatti et al(2007); and the 6.0% found in the work of Egah et al (2004). 
 
This figure is higher  than the 0.2% found among voluntary blood donors in Nairobi  in the work of Abdalla et al 
(2005); the 0.5% among donors in Niger- delta arrear of Nigeria.  Ejele et al (2005); However Elfaki et al (2008) 
found no case of HCV infection in the 260 Sudanese blood donors they studied.  
 
5.1.1 
The wide differences in the HBV and HCV infection rate among the voluntary blood donors in the different 
regions within and outside Lagos may be due to the differences in geographical locations, age range of donor 
patients, the period of time the studies were carried out, difrence in sexual behavior use of drugs, Access to 
healthcare, Immunization practices, laboratory test reagents competence of laboratory personnel, government 
regulation and health facility monitoring. 
 
5.1.2 
CONCLUSION: The result revealed a decline in prevalence of viral hepatitis among voluntary donors in private 
laboratories in Lagos. 
This cannot be unconnected with the regulatory and monitoring of blood transfusion by authorities of Lagos state 
government.  
It is recommended that governments of south western states in Nigeria put in place effective monitoring 
faciliticies for  safe blood transfusion if safe blood transfusion and 0% prevalence in viral hepatitis would be 
achieved in blood donors in Lagos. 
 
REFERENCES 
Abdalla F., O.W. Mwanda, F. Rana, 2005. Comparing walk-in and call-responsive donors in a national and a 
private hospital in Nairobi. East African Medical Journal.,82(10):532-536. 
Abdalla F., O.W. Mwanda, F. Rana, 2005. Comparing walk-in and call-             responsive donors in anational 
and a private hospital in Nairobi. East African Medical Journal.,82(10):532-536. 
Abdusalai Nasidi, Tekena Harry et al. vol 15 issue 2 PP 274 – 276. Epidemiology of chronic hepatitis infection 
in sub-Sahara Africa (lancet infect. Dis. 2002 
Abdusalami Nasidi,Tekena Harry et.al. prevalence of hepatitis B infection markers representative arrears of 
Nigeria; international journal of epidemiology vol. 15 issue 2 pp274-276. 
Ayolabi   C. I, Taiwo M.A, Omilabu S.A, et al(2006). Seroprevalence of hepatitis C virus among blood donors in 
Lagos Nigeria. African journal of biotechnology vol. 65 (20) pp 1994 – 1996) 
Ayoola E. A. Adelaja A. B. (1998) Sub-determinants and incidence of hepatitis B. antigen in curriers A hepatitis 
of surface antigen. Nigerian journal of medical practitioners  Vol. 11 pp 133 – 136 
Behzad-Behbahani A., A. Mafi-Nejad, S.Z. Tabei, K.B. Lankarani, A. Torab, A. Moaddeb, 2006.                      
Anti-HBc and HBV DNA detection in blood donors negative for hepatitis B virus surface    antigen in 
reducing risk of transfusion associated HBV infection. Indian J Med Res.,123(1):3742.  
Behzad-Behbahani A., A. Mafi-Nejad, S.Z. Tabei, K.B. Lankarani, A. Torab, A. Moaddeb, 2006. Anti-HBc and 
HBV DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of 
transfusion associated HBV infection. Indian J Med Res.,123(1):37-42.  
Bhattacharya P., P.K. Chandra, S. Datta, A. Banerjee, S. Chakraborty, K. Rajendran K et al.,2007. Significant 
increase in HBV, HCV, HIV and Syphilis among blood donors in West Bengal, Eastern India. World J 
Gastroenterol.,13(27):3730-3733. 
 Bhattacharya P., P.K. Chandra, S. Datta, A. Banerjee, S. Chakraborty, K. Rajendran K et al.,2007. Significant 
increase in HBV, HCV, HIV and Syphilis among blood donors in West Bengal, Eastern India. World J 
Gastroenterol.,13(27):3730-3733. 
Bhatti F.A., Z. Ullah, N. Salamat, M. Ayub, E. Ghani, 2007. Anti-hepatitis B core antigen testing, viral markers, 
and occult hepatitis B virus infection in Pakistani blood donors: implication for transfusion practice. 
Transfusion., 47(1):74-79. 
 Bhatti F.A., Z. Ullah, N. Salamat, M. Ayub, E. Ghani, 2007. Anti-hepatitis B core antigen testing, viral markers, 
and occult hepatitis B virus infection in Pakistani blood donors: implication for transfusion practice. 
Transfusion., 47(1):74-79. 
Cheng D.S.,1995. Hepatitis C virus in chronic liver disease and Hepatocellular carcinoma inTaiwan. Princess 
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) 
Vol.5, No.3, 2015 
 
69 
Takamatsu symp., 25:27-32. 
 Cheng D.S.,1995. Hepatitis C virus in chronic liver disease and Hepatocellular carcinoma in Taiwan. Princess 
Takamatsu symp., 25:27-32. 
Colquhon S.D.,1996. Hepatitis C: A clinical update. Arch Surg.,131:18-23. 
 Colquhon S.D.,1996. Hepatitis C: A clinical update. Arch Surg., 131:18-23. 
 Egah D.Z., B.M. Mandong, D. Iya, N.E. Gomwalk, E.S. Audu, E.B. Banwat et al., 2004. Hepatitis C virus 
antibodies among blood donors in Jos, Nigeria. Annals of African Medicine.,3(1):35-37. 
Ejele O.A., O. Erhabor, C.A. Nwauche, 2005. The risk of transfusion-transmissible viral infections in the Niger-
Delta area of Nigeria. Sahel Medical Journal.,8(1):16-19. 
Elfaki A.M., A.A. Eldour, N.M. Elsheikh, 2008. Sero-prevalence of immunodeficiency virus, hepatitis B and C 
and syphilis among blood donors at ElObeid Teaching Hospital, West Sudan. Sudan Journal of 
Medical Sciences.,3(4):333-338. 
 Elfaki A.M., A.A. Eldour, N.M. Elsheikh, 2008. Sero-prevalence of immunodeficiency virus, hepatitis B and C 
and syphilis among blood donors at ElObeid Teaching Hospital, West Sudan. Sudan Journal of 
Medical Sciences.,3(4):333-338. 
Esumeh F.I., D. Ugbomoiko, J.O. Isibor, 2003. Seroprevalence of HIV and Hepatitis B surface antigen (HBsAg) 
among blood donors in central hospital, Benin city, Nigeria. Journal of Medical Laboratory 
Science.,12(2):52-55. 
 Esumeh F.I., D. Ugbomoiko, J.O. Isibor, 2003. Seroprevalence of HIV and Hepatitis B surface antigen (HBsAg) 
among blood donors in central hospital, Benin city, Nigeria. Journal of Medical Laboratory 
Science.,12(2):52-55. 
 Ezeani M.C., O. Oluchi, C.C. Onyenekwe, S.C. Meludu, J.E. Okonkwo, 2006. Prevalence of Hepatitis B and C 
virus infection among blood donors and abnormal ALT activities in blood donors in Nigeria. Journal 
of Biomedical Investigation.,4(2):32-36. Viral Hepatitides in Voluntary Blood Donors in Yola, Nigeria 
334 
Fasola F.A., T.R. Kotila, J.O. Akinyemi, 2009. Trends in transfusion-transmissible viralinfections from 2001 to 
2006 in Ibadan, Nigeria. Intervirology.,51(6):427-431. 
Gashau W., I. Mohammed, 1991. Hepatitis B virus markers in Nigerian patients with Primary Liver Cell 
Carcinoma. Trop Geog Med., 43:64-67. 
Gimson AE (July 1996) fulmnant and late onset hepatic failure. British journal of anesthetics vol.77 (1) pp90-98  
Ibrahim B. S. (2005) Islamic medicine: 1000 years ahead of its times. Journal of Islamic medical association vol. 
2 – pp2 – 9 
 Isselbacher K.J., J.R. Wands, 1991. Neoplasms of the Liver, In Harrison’s principles of Internal Medicine. 12th 
Ed. New York. Wilson JD, Braunwald E, Isselbacher K et al (eds). Mc Graw Hill.,1350-1352. 
 Isselbacher K.J., J.R. Wands, 1991. Neoplasms of the Liver, In Harrison’s principles of Internal Medicine. 12th 
Ed. New York.  
 Kagu M.B., M.B. Kawuwa, A.O. Ayilara, B.Z. Ali, 2005. Seroprevalence of HIV and hepatitis viruses in 
directed blood donors: a preliminary report. Highland Medical Research Journal.,3(2):76-80. 
 Kagu M.B., M.B. Kawuwa, A.O. Ayilara, B.Z. Ali, 2005. Seroprevalence of HIV and hepatitis viruses in 
directed blood donors: a preliminary report. Highland Medical Research Journal.,3(2):76-80. 
 Khan Z., F. Raziq, N. Aslam, 2002. Prevalence of HIV in N.W.F.P. Journal of Postgraduate Medical 
Institute.,16(2):187-189. 
 Khan Z., F. Raziq, N. Aslam, 2002. Prevalence of HIV in N.W.F.P. Journal of Postgraduate Medical 
Institute.,16(2):187-189. 
Lass Natik, Tesfay fessehaye (2011)-a retrospective analysis from national blood transfusion analysis.erteria.pan 
Africa medical journal vol.9 p 40. Prevalence of hepatitis of infections making in representative areas 
of Nigeria; international journal of epidemiology,  
 Lesi O.A., M.O. Kehinde, E.E. Anomneze, S.S. Wali, 2002. Hepatitis C infection and the risk of chronic liver 
disease in Lagos. Nig Q J Hosp Med.,12:1-4. 
 Maddava V., C. Burgess, E. Drucker, 2002. Epidemiology of chronic hepatitis co- infection in sub-Saharan 
Africa. Lancet, Infectious disease., 2:293-302. 
 Matee M.I., E.F. Lyamuya, E.C. Mbena, P.M. Magessa, J. Sufi, G.J. Marwa et al., 1999. Prevalence of 
transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, 
Dar es Salaam, Tanzania. East Afr Med J.,76(3):167-171. 
 Muktar H.M., A.M. Suleiman, M. Jones, 2005. Safety of blood transfusion: prevalence of hepatitis B surface 
antigen in blood donors in Zaria, Northern Nigeria. Nigerian journal of Surgical Research.,7(3&4): 
290-292. 
 Muktar H.M., A.M. Suleiman, M. Jones, 2005. Safety of blood transfusion: prevalence of hepatitis B surface 
antigen in blood donors in Zaria, Northern Nigeria. Nigerian journal of Surgical Research.,7(3&4): 
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) 




 Nahom fessehaye, Doughlas Natik, Teesfay Fessehaye (2011)- retrospective analysis from national blood 
transfusion Eriteria. The pan-Africa medical journal vol.9.p40 
 Nwokediuko S.C., O.G. Ibegbulam, T. Ugwu, 2007. Hepatitis C virus seroprevalence in blood donors at the 
University of Nigeria Teaching Hospital, Enugu. Journal of College of Medicine.,12(2):85-88. 
Olokoba A.B, .Salau F.K,et.al viral hepatitis in voluntary donors; European  journal of science vol.5 (2009) 
pp32-34 
 Olokoba A.B., L.B. Olokoba, F.K. Salawu, A. Danburam,O.O. Desalu, J. Midala et al., 2008. Res. J. Med. 
Sci.,2(5):217-219. 
Schreiber G.B., M.P. Busch, S.H. Kleinman, J.J. Korelitz, 1996. The risk of transfusion transmitted viral 
infections. The retrovirus epidemiology donor study. N Engl J Med., 334:1685-1690. 
Uneke C. J. Ogbu-O. PU Inyama, G. I Anyanwu, MO Njoku, J. H Idoko (2005) prevalence of hepatitis B of 
surface antigen among blood donors in jos Nigeria Memo institute Oswald Cruz. Rio de janero vol. 
1000(1)PP 13 – 16. 
Waheed u. abass H., Naseem L. Hassan K. study of hepatitis B and C virus zero positivity in healthy donors and 
pale. Inst. Med. Science. 2009;5 233 – 6 
 
TABLE (i)    AGE DISSTRIBUTION OF HEPATITIS B AMONG DONORS IN PRIVATE 
LABORATORIES 










21-30 135(42.9%) 128(94.8%) 7(5.2%) 7(5.2%)  128(94.8%) 
31-40 114(36.2%)  106(93%) 8(7%) 8(7.1%) 106(92.7%) 
41-50 39(12.3%) 37(94.9%) 2(3.1%) 0(0%) 37(99.4%) 
51-60 18(5.7%)  18(100%) 0(0%)  0(0%) 18(100%) 
61-70 9(2.9%) 9(100%) 0(0%) 0(0%) 9(100%) 
The table shows prevalence of hepatitis B surface antigen at every decade of life of voluntary donors 
TABLE ii  
INCIDENCE OF HEPATITIS B AMONG SEX 
SEX POSITIVE NEGATIVE TOTAL 
MALE  12(4.0%) 286(96.0%) 298 
FEMALE 3(17.3%) 14(82.5%) 17 
TOTAL 15(4.3%) 305 315 
The table shows the prevalence of HBsAg among donors along gender distribution 
TABLE iii  
AGE DISTRIBUTION OF HEPATITIS C AMONG BLOOD DONORS IN PRIVATE LABORATORIES 










21-30 135 (42.9%) 128(94.8%) 
/7(5.2%) 
2(1.5%) 133(98.5%) 
31-40 114 (36.2%) 106(93%)/ 8(7%) 0(0%) 114(100%) 
41-50 39 (12.3%) 37(94.9%) /2(5.1%) 0(0%) 39(100%) 
51-60 18 (5.7%) 18(100%)/ 0(0%) 0(0%) 18(100%) 
61-70                 9 (2.9%) 9(100%)/ 0(0%) 0(0%)  9(100%) 
 
The table shows prevalence of hepatitis C virus  antibody among blood donors at every decade of life  
TABLE iv 
 INCIDENCE OF HEPATITIS C AMONG SEX 
SEX POSITIVE  NEGATIVE TOTAL 
MALE 1(0.3%) 297(99.7%) 298 
FEMALE 1(6.3%) 16(93.7%) 17 
TOTAL   2(6.6%) 303(99.4%) 315 
The table shows prevalence of hepatitis C virus among blood donors along gender distribution. 
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